Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
7
result was found. Results that relate to
Pembrolizumab
One case of maculopapule induced by amoxicillin after pembrolizumab treatment
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(1):95-98.
1083 times
552 times
Jing GONG
Xiao-Lin CHEN
Xue-Li LIU
Jun YANG
Pembrolizumab
Amoxicillin
Maculopapular drug eruption
Immune activation
Details
Case report and literature analysis of hypothyroidism induced by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(2):227-232.
1492 times
632 times
Fei-Long TAN
Hong-Ying XIA
Zhong-Juan WANG
Li DING
Li-Na YOU
Li ZHOU
Jian JIN
Pembrolizumab
Immune checkpoint inhibitors
Hypothyroidism
Adverse drug reaction
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1311-1315.
1459 times
472 times
Jin-Jin ZOU
Ji-Liang ZHANG
Ni LI
Ding-Yi LIU
Pembrolizumab
Lung squamous cell carcinoma
Severe immune-related ulcerative colitis
Adverse drug reactions
Details
A case of severe immune liver injury caused by pembrolizumab and rechallenge
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(2):212-217.
833 times
413 times
LIU Min
YANG Limei
YIN Yue
ZHAO Bingqing
Pembrolizumab
Immune related liver injury
Rechallenge of immunotherapy
Details
Cost-utility analysis of pembrolizumab combined with chemotherapy for advanced malignant pleural mesothelioma
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1107-1114.
326 times
60 times
HU Yunjia
ZOU Keqing
HOU Yanhong
Pembrolizumab
Chemotherapy
Advanced malignant pleural mesothelioma
Partitioned survival model
Cost-utility analysis
Pharmacoeconomic evaluation
Details
One case of anaphylaxis caused by pembrolizumab injection
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1196-1200.
276 times
60 times
HUANG Shuzhen
CHEN Xiongjian
Pembrolizumab
Anaphylaxis
Adverse drug reaction
Details
A case of toxic epidermal necrolysis caused by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
New Online
214 times
36 times
HUANG Lingling
LI Xialin
HUANG Guangyao
LUO Peng
WANG Weimin
WANG Junping
Pembrolizumab
Lung cancer
Toxic epidermal necrolysis
Adverse drug reaction
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University